0001209191-16-119300.txt : 20160511
0001209191-16-119300.hdr.sgml : 20160511
20160511184141
ACCESSION NUMBER: 0001209191-16-119300
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160502
FILED AS OF DATE: 20160511
DATE AS OF CHANGE: 20160511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neothetics, Inc.
CENTRAL INDEX KEY: 0001618835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208527075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: (858) 750-1008
MAIL ADDRESS:
STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feldman Maria
CENTRAL INDEX KEY: 0001674083
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36754
FILM NUMBER: 161641213
MAIL ADDRESS:
STREET 1: 9171 TOWNE CENTRE DRIVE, SUITE 270
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-05-02
0
0001618835
Neothetics, Inc.
NEOT
0001674083
Feldman Maria
9171 TOWNE CENTRE DRIVE, SUITE 270
SAN DIEGO
CA
92122
0
1
0
0
VP Clinical Research & Opera
Stock Option (Right to Buy)
1.342
2024-03-10
Common Stock
21498
D
Stock Option (Right to Buy)
6.79
2025-02-10
Common Stock
14727
D
Stock Option (Right to Buy)
6.79
2025-02-10
Common Stock
3273
D
Stock Option (Right to Buy)
0.9701
2026-02-04
Common Stock
25000
D
Twenty-five (25%) of the option shares shall vest on the one (1) year anniversary from the vesting commencement date March 1, 2014, and the option shares shall vest in in thirty-six (36) equal monthly installments thereafter, subject to the reporting person continuing to be a service provider to the issuer through each vesting date.
Option shares shall vest in forty-eight (48) equal monthly installments from the vesting commencement date February 10, 2015, subject to the reporting person continuing to be a service provider to the issuer through each vesting date.
Option shares shall vest in forty-eight (48) equal monthly installments from the vesting commencement date February 4, 2016, subject to the reporting person continuing to be a service provider to the issuer through each vesting date.
Exhibit 24 - Power of Attorney
/s/ Maria Feldman
2016-05-11
EX-24.3_653470
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and
appoints Susan Knudson, individually, their true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or 10% or greater stockholder of Neothetics, Inc.
(the "Company"), any and all Form 3, 4 and 5 reports required to be filed by the
undersigned in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended, and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
report and timely file such report with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned, pursuant to this Power of Attorney, shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in her
discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform each and every act and thing whatsoever requisite, necessary,
and proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or her substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted. The undersigned acknowledges
that no such attorney-in-fact, in serving in such capacity at the request of the
undersigned, is hereby assuming, nor is the Company hereby assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Form 3, 4 and 5 reports with respect
to the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 5th day of May, 2016.
Signature
/s/ Maria Feldman
Print Name